Commonwealth Cancer Consortium Inc
- Assets
- $73.2m
- Revenue
- $2.4m
- Investments
- $0.0
- Employees
- 20
- Location
- Cambridge, MA
- Founding
- Data as of
- 12/2023
- EIN
- 85-1681659
Organization Overview
Commonwealth Cancer Consortium Inc, operating under the name Break Through Cancer, is located in Cambridge, MA. As of 12/2023, Break Through Cancer employed 20 individuals. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. Break Through Cancer is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
For the year ending 12/2023, Break Through Cancer generated $2.4m in total revenue. This organization has experienced exceptional growth, as over the past 4 years, it has increased revenue by an average of 72.8% each year . All expenses for the organization totaled $32.2m during the year ending 12/2023. You can explore the organizations financials more deeply in the financial statements section below.
Form
990
Mission & Program ActivityExcerpts From the 990 Filing
TAX YEAR
2023
Describe the Organization's Mission:
Part 3 - Line 1
BREAK THROUGH CANCER IS A FOUNDATION DEDICATED TO SUPPORTING TRANSLATIONAL RESEARCH IN THE MOST DIFFICULT TO TREAT CANCERS. OUR PARTNER ORGANIZATIONS ARE AMONG THE TOP CANCER RESEARCH CENTERS AND TOGETHER, REPRESENT SOME OF THE MOST BRILLIANT, CREATIVE MINDS IN THE COUNTRY. WE BELIEVE BREAK THROUGH CANCER IS THE BEGINNING OF A SCIENTIFIC MOVEMENT THAT ACCEPTS NOTHING LESS THAN MULTI-INSTITUTIONAL COLLABORATION IN PATIENT CENTRIC CANCER RESEARCH. THE FOUNDATION WILL WORK CLOSELY WITH TEAMS OF SCIENTISTS, ENGINEERS, AND CLINICAL RESEARCHERS TO FOCUS ON DIAGNOSING, TREATING, AND IDEALLY CURING SOME OF THE MOST INTRACTABLE FORMS OF CANCER. WHILE MANY PATIENTS HAVE BENEFITED FROM ADVANCES IN RESEARCH AND TECHNOLOGY, THERE ARE FAR TOO MANY WHO HAVE BEEN LEFT BEHIND. THERE ARE TOO MANY CANCERS WHERE THE NEEDLE REMAINS UNMOVED. BREAK THROUGH CANCER IS COMMITTED TO MAKING HEADWAY IN THESE EXTREMELY COMPLEX, CHALLENGING DISEASES, AND COMMITTED TO FINDING HOPE FOR PATIENTS AND THEIR FAMILIES.
Describe the Organization's Program Activity:
Part 3 - Line 4a
PROVIDES FUNDING TO TEAMS OF RESEARCHERS FROM THE FIVE TOP CANCER RESEARCH CENTERS: DANA-FARBER CANCER INSTITUTE, THE SIDNEY KIMMEL COMPREHENSIVE CANCER CENTER AT JOHN HOPKINS, MASSACHUSETTS INSTITUTE OF TECHNOLOGY'S KOCH INSTITUTE FOR INTEGRATIVE CANCER RESEARCH, THE UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER, AND MEMORIAL SLOAN KETTERING CANCER CENTER IN ORDER TO HELP INTERCEPT CANCER EARLY, DEVELOP MORE EFFECTIVE TREATMENTS, AND ACCELERATE CURES FOR SOME OF THE DEADLIEST CANCERS.
Get More from Intellispect for FreeCreate a free account to get more data, nonprofit salaries, advanced search and more.
PDF Copies of 990 Filings
Board, Officers & Key Employees
| Name (title) | Role | Hours | Compensation |
|---|---|---|---|
Bill Goodwin Director | Trustee | 1 | $0 |
Alice Goodwin Director | Trustee | 1 | $0 |
John Sherman Director | Trustee | 1 | $0 |
Susan Hockfield Director | Trustee | 1 | $0 |
Giulio Draetta Director | Trustee | 1 | $0 |
David Jaffray Director | Trustee | 1 | $0 |
Outside Vendors & Contractors
| Vendor Name (Service) | Service Year | Compensation |
|---|---|---|
Sage Bionetworks Data Science Engineering | 12/30/23 | $376,250 |
Fovndry Pr Media Support | 12/30/23 | $137,638 |
Cooley Llp Legal | 12/30/23 | $114,661 |
Gordon Saksena Llc Data Science Engineering | 12/30/23 | $113,425 |
Faber Daeufer & Itrato Pc Legal | 12/30/23 | $108,258 |
Financial Statements
| Statement of Revenue | |
|---|---|
| Federated campaigns | $0 |
| Membership dues | $0 |
| Fundraising events | $0 |
| Related organizations | $0 |
| Government grants | $0 |
| All other contributions, gifts, grants, and similar amounts not included above | $2,380,369 |
| Noncash contributions included in lines 1a–1f | $0 |
| Total Revenue from Contributions, Gifts, Grants & Similar | $2,380,369 |
| Total Program Service Revenue | $0 |
| Investment income | $5,773 |
| Tax Exempt Bond Proceeds | $0 |
| Royalties | $0 |
| Net Rental Income | $0 |
| Net Gain/Loss on Asset Sales | $0 |
| Net Income from Fundraising Events | $0 |
| Net Income from Gaming Activities | $0 |
| Net Income from Sales of Inventory | $0 |
| Miscellaneous Revenue | $0 |
| Total Revenue | $2,386,142 |
| Statement of Expenses | |
|---|---|
| Grants and other assistance to domestic organizations and domestic governments. | $0 |
| Grants and other assistance to domestic individuals. | $0 |
| Grants and other assistance to Foreign Orgs/Individuals | $0 |
| Benefits paid to or for members | $0 |
| Compensation of current officers, directors, key employees. | $1,468,346 |
| Compensation of current officers, directors, key employees. | $613,054 |
| Compensation to disqualified persons | $0 |
| Other salaries and wages | $1,507,710 |
| Pension plan accruals and contributions | $134,772 |
| Other employee benefits | $195,061 |
| Payroll taxes | $173,862 |
| Fees for services: Management | $0 |
| Fees for services: Legal | $274,239 |
| Fees for services: Accounting | $0 |
| Fees for services: Lobbying | $39,500 |
| Fees for services: Fundraising | $0 |
| Fees for services: Investment Management | $0 |
| Fees for services: Other | $18,529 |
| Advertising and promotion | $244,310 |
| Office expenses | $31,866 |
| Information technology | $64,657 |
| Royalties | $0 |
| Occupancy | $255,215 |
| Travel | $143,652 |
| Payments of travel or entertainment expenses for any federal, state, or local public officials | $0 |
| Conferences, conventions, and meetings | $660,170 |
| Interest | $0 |
| Payments to affiliates | $0 |
| Depreciation, depletion, and amortization | $0 |
| Insurance | $22,865 |
| All other expenses | $29,755 |
| Total functional expenses | $32,184,501 |
| Balance Sheet | |
|---|---|
| Cash—non-interest-bearing | $3,324,464 |
| Savings and temporary cash investments | $0 |
| Pledges and grants receivable | $69,061,427 |
| Accounts receivable, net | $0 |
| Loans from Officers, Directors, or Controlling Persons | $0 |
| Loans from Disqualified Persons | $0 |
| Notes and loans receivable | $0 |
| Inventories for sale or use | $0 |
| Prepaid expenses and deferred charges | $2,815 |
| Net Land, buildings, and equipment | $0 |
| Investments—publicly traded securities | $0 |
| Investments—other securities | $0 |
| Investments—program-related | $0 |
| Intangible assets | $0 |
| Other assets | $814,653 |
| Total assets | $73,203,359 |
| Accounts payable and accrued expenses | $1,090,372 |
| Grants payable | $0 |
| Deferred revenue | $0 |
| Tax-exempt bond liabilities | $0 |
| Escrow or custodial account liability | $0 |
| Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
| Secured mortgages and notes payable | $0 |
| Unsecured mortgages and notes payable | $0 |
| Other liabilities | $838,047 |
| Total liabilities | $1,928,419 |
| Net assets without donor restrictions | $34,488,323 |
| Net assets with donor restrictions | $36,786,617 |
| Capital stock or trust principal, or current funds | $0 |
| Paid-in or capital surplus, or land, building, or equipment fund | $0 |
| Retained earnings, endowment, accumulated income, or other funds | $0 |
| Total liabilities and net assets/fund balances | $73,203,359 |